Adam Rana, MD
Orthopaedic Surgery · Falmouth, MENPI 1922273143
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (46.9%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 98.2% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2022 at $129,008 and has fallen 76.9% since, to $29,746 in 2025. Among orthopaedic surgery clinicians in ME with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 292 payments — averaging $1129.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$324K
- Zimmer Biomet$2K
- Heron Therapeutics, Inc.$2K
- Pacira Pharmaceuticals Incorporated$494
- Kairos Surgical Inc$438
- Stryker$156
- plus $413 from 5 others
Across 9 payments — averaging $16,985 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Smith+Nephew$118K
- Zimmer Biomet$35K
What the payments were for
- Consulting fees$99,45830%
- Speaking & faculty fees$154,78747%
- Travel & lodging$61,79419%
- Food & beverage$13,2034%
- Education$4740%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 248 | $323,825 |
| Zimmer Biomet | 28 | $2,336 |
| Heron Therapeutics, Inc. | 2 | $2,053 |
| Pacira Pharmaceuticals Incorporated | 5 | $494 |
| Kairos Surgical Inc | 1 | $438 |
| Stryker | 2 | $156 |
| AbbVie | 1 | $114 |
| Restor3d, Inc. | 1 | $102 |
| Medtronic | 1 | $89 |
| Organogenesis Inc. | 2 | $84 |
| Arthrex | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Journey II$285,310
- REAL INTELLIGENCE$112,357
- POLARSTEM$99,376
- REDAPT$83,212
- Tandem$79,631
- Anthology$61,344
- POLARCUP$54,676
- OR3O Dual Mobility$52,254
- R3 ACETABULAR$45,253
- K-15 PORK$23,888
- POLAR3$23,477
- Engage Partial Knee System$22,022
- OR3O$20,641
- Legion$16,354
- OXINIUM Hip$11,126
- RI.HIP NAVIGATION$10,163
- R3$9,243
- Legion Revision$7,850
- Journey II XR$5,866
- JOURNEY II UK$3,150
How this compares
$329,715 in reported general payments places this provider in the 95th percentile of 111 orthopaedic surgery providers in Maine.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 27 | $256 |
| Amoxicillin | 67 | $164 |
| Meloxicam | 15 | $20 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Falmouth
- George BabikianFalmouth$446K
- Nicholas ColacchioFalmouth$439K
- John HerzogFalmouth$258K
- Stephen RodrigueFalmouth$12K
- Gregory SawyerFalmouth$11K
- Mats AgrenFalmouth$2K
- Matthew CamusoPortland$120K
- Ian DickeyFarmington$75K
- Daniel ShubertAugusta$64K
- Gregory PomeroyPortland$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.